Mentions
Extended reach
Total likes
Video views
AI synopsis
Numerous discussions reference the publication's key points about vaccine development timelines and complexities, with some comments querying why creating a vaccine typically takes years. Phrases like 'excellent review' and 'useful snapshot' highlight the importance of this information, while terms such as 'game changer' and 'serious concern' indicate a mix of hope and caution regarding vaccine efficacy and safety.
Many discussions show support for the publication's findings regarding vaccine development and its challenges.
Participants express high curiosity about the topic and its relevance in the context of the ongoing pandemic.
Some conversations delve into specifics of vaccine development processes, though not all posts demonstrate profound engagement.
Users perceive that the article could have significant implications for future vaccine strategies.
ICYMI: Perspective from @florian_krammer & @FatimaAmanat on #vaccine development for #SARSCoV2: "SARS-CoV-2 Vaccines: Status Report" https://t.co/HPDhHs2PSc #COVID19 #openaccess https://t.co/h36fVNsPLn
If you are interested to know the status of #SARSCoV2 #vaccine. Copied below the link. Thank you @ImmunityCP make it free for all. https://t.co/BtlM89bGId https://t.co/HiRxaQcemn
Everything you might want to know about the future #vaccine against #SARSCoV2 #COVID19 @florian_krammer @ImmunityCP @Immunoscope @Immune_News https://t.co/UM3QUU8nlK
ワクチン開発の現状と課題がとても良くわかります。モダリティごとの表も理解を助けます。 SARS-CoV-2 Vaccines: Status Report: Immunity https://t.co/Tn5KWlv4lN
This is a useful snapshot on #SARSCoV2 #vaccines in development. https://t.co/KcDtEFSllv For a more detailed review https://t.co/kReeLgcLIt https://t.co/U5PC7ydy6Q
Nice review about #SARS_COV_2 from @florian_krammer and @FatimaAmanat https://t.co/CiymeuJyy7
Studies show that vaccines against COVID-19 are in rapid development. While none are effective yet, global efforts aim to create a vaccine that could save millions of lives. Learning from this process is crucial for…
In this week's episode, we explore the vaccine development process for SARS-CoV-2 and analyze new transcriptome data. Understanding these aspects is crucial for creating effective vaccines against future emerging…
SARS-CoV-2, responsible for COVID-19, emerged in late 2019, leading to significant global health challenges. This video provides an overview of the current status of vaccine development and its importance in mitigating…
SARS-CoV-2 Vaccines: Status Report https://t.co/jjrzQqAm9V
https://t.co/3ZJ31ooJki
Separate Vaccine for Omicron?? See Experts Suggestion!!! https://t.co/ogCmvKfC61 via @Exams Daily - India's no 1 Education Portal
SARS-CoV-2 Vaccines: Status Report https://t.co/jtKdnC6yoI
RT @Ake_DrMEE: doi: 10.1016/j.immuni.2020.03.007, doi: 10.1016/j.virusres.2020.198114, doi: 10.12688/f1000research.25998.1, doi: 10.1038/s4…
RT @Ake_DrMEE: doi: 10.1016/j.immuni.2020.03.007, doi: 10.1016/j.virusres.2020.198114, doi: 10.12688/f1000research.25998.1, doi: 10.1038/s4…
RT @Ake_DrMEE: doi: 10.1016/j.immuni.2020.03.007, doi: 10.1016/j.virusres.2020.198114, doi: 10.12688/f1000research.25998.1, doi: 10.1038/s4…
RT @Ake_DrMEE: doi: 10.1016/j.immuni.2020.03.007, doi: 10.1016/j.virusres.2020.198114, doi: 10.12688/f1000research.25998.1, doi: 10.1038/s4…
RT @Ake_DrMEE: doi: 10.1016/j.immuni.2020.03.007, doi: 10.1016/j.virusres.2020.198114, doi: 10.12688/f1000research.25998.1, doi: 10.1038/s4…
RT @Ake_DrMEE: doi: 10.1016/j.immuni.2020.03.007, doi: 10.1016/j.virusres.2020.198114, doi: 10.12688/f1000research.25998.1, doi: 10.1038/s4…
RT @Ake_DrMEE: doi: 10.1016/j.immuni.2020.03.007, doi: 10.1016/j.virusres.2020.198114, doi: 10.12688/f1000research.25998.1, doi: 10.1038/s4…
RT @Ake_DrMEE: doi: 10.1016/j.immuni.2020.03.007, doi: 10.1016/j.virusres.2020.198114, doi: 10.12688/f1000research.25998.1, doi: 10.1038/s4…
doi: 10.1016/j.immuni.2020.03.007, doi: 10.1016/j.virusres.2020.198114, doi: 10.12688/f1000research.25998.1, doi: 10.1038/s41563-020-0746-0 #ถ้าผู้นำตายเราจะรอดกันหมด #รัฐบาลส้นตีน #รัฐบาลขยะ #Novavax #ซิโนแวคคือการคอรัปชั่น
@HenkJZoer @EngineerJW @IedemaEls @susket46627052 @willem_engel SARS-CoV-2 vaccines: status report The architecture of SARS-CoV-2 transcriptome deze twee papers laten zien dat de enzyme opbouw hetzelfde is.
SARS-CoV-2 Vaccines: Status Report https://t.co/8QrOvdF5RT
https://t.co/ruqrURzkG4
https://t.co/GVr2wIgLtr
3.- Amanat F., Krammer F. SARS-CoV-2 vaccines: status report. Immunity. 2020. https://t.co/RD5E09AZGF (18-21)
RT @paulofarber: Vacinas para #COVID19 . Ainda vai demorar muito para uma vacina segura e eficaz. Alguns tipos de vacinas geram preocupação…
el SARS-CoV-2? Sígueme y te seguiré contando de las empresas, universidades que están desarrollando estas vacunas. Fuente de la imagen: The Lancet BBC. Referencias. 1.- Amanat F, Krammer F. SARS-CoV-2 vaccines: status report. Immunity. 2020. https://t.co/RD5E09AZGF (14/19)
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ - GIGAZINE https://t.co/TKcy21oLRj
RT @illyankash_chan: 新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ https://t.co/rnaffEM9V2
Retweeted from Eric Topol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co/25Al3QOGta @IcahnMountSinai @IcahnInstitute @SinaiImmunol via @dlammerts A key point: it'll take l https://t.co/Xp48ctwhKA
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @beriko0214: SARS-CoV-2 Vaccines: Status Report https://t.co/D2VqbO2068
SARS-CoV-2 Vaccines: Status Report https://t.co/D2VqbO2068
Aquí hay un enlace al artículo en @CellPressNews escrito por @FatimaAmanat y @florian_krammer https://t.co/F1jPKBiEDA
RT @nicktatonetti: In this week's episode of #TheC19Weekly we discuss #vaccines, #transcriptomics data, and what models of digital contact…
SARS-CoV-2 vacines with a focus on vaccine development and its challenges. https://t.co/FwpEAHAsDZ #CoV2 #diagnostics #labmedicine #covid19 #veravas
RT @VincentRK: And a very useful Table from this paper. https://t.co/qTxVvTWfce https://t.co/S0Kn6b6IRs
RT @VincentRK: 7) A great resource on COVID vaccine development process and timelines: @FatimaAmanat @florian_krammer paper in Cell. @CellP…
RT @JenniferSpicer4: Here's a link to the perspective piece in @CellPressNews by @FatimaAmanat & @florian_krammer https://t.co/UQGtl1Wpbf…
Here's a link to the perspective piece in @CellPressNews by @FatimaAmanat & @florian_krammer https://t.co/UQGtl1Wpbf And a link to our webpage that hosts the literature summaries from our #EmoryID fellows and visuals from our medical students https://t.co/b9Dp1hhlWm
Perspective from @florian_krammer & @FatimaAmanat on #vaccine development for #SARSCoV2: SARS-CoV-2 Vaccines: Status Report #COVID19 #openaccess https://t.co/zW6KC4DYja
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ - GIGAZINE https://t.co/a4pRZiqXHe
で、更にこの記事も読んで 新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ - GIGAZINE https://t.co/Ivy93G8dsD
RT @florian_krammer: So here is a Perspective on development of vaccines (and antivirals) for COVID19/SARS-CoV-2 and why it takes sot long:…
SARS-CoV-2 Vaccines: Status Report @CellCellPress https://t.co/iXypOv3XL6
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ - GIGAZINE https://t.co/Rifs0E1nUa
RT @brenner_dirk: Great reference! @florian_krammer SARS-CoV-2 Vaccines: Status Report https://t.co/0xVnoZg5BH
Great reference! @florian_krammer SARS-CoV-2 Vaccines: Status Report https://t.co/0xVnoZg5BH
@profvrr Good point. And a lot could have been done in those last 17 years to be better prepared for vaccine candidates (eg safety studies). Interesting review: https://t.co/MftWcIOObV
SARS-CoV-2 Vaccines: Status Report: Immunity
https://t.co/6boDnyJjL6
RT @Aiims1742: This is a useful snapshot on #SARSCoV2 #vaccines in development. https://t.co/KcDtEFSllv For a more detailed review https:…
RT @Aiims1742: This is a useful snapshot on #SARSCoV2 #vaccines in development. https://t.co/KcDtEFSllv For a more detailed review https:…
@CNBCnow @megtirrell preparation of vaccine has started everywhere, but it seems a long way to go. "SARS-CoV-2 Vaccines: Status Report" Immunity 52, April 14, 2020 https://t.co/YHZCOhoXj1
RT @Aiims1742: This is a useful snapshot on #SARSCoV2 #vaccines in development. https://t.co/KcDtEFSllv For a more detailed review https:…
RT @Aiims1742: This is a useful snapshot on #SARSCoV2 #vaccines in development. https://t.co/KcDtEFSllv For a more detailed review https:…
This is a useful snapshot on #SARSCoV2 #vaccines in development. https://t.co/KcDtEFSllv For a more detailed review https://t.co/kReeLgcLIt https://t.co/U5PC7ydy6Q
・ワクチン開発の現状と見通し Ammanat and Krammer, SARS-CoV-2 Vaccines: Status Report. Immunity 4月6日オンライン版 https://t.co/WfKAZVpvxA 山中伸弥先生のHPには流石に質の高い論文が揃っていて要チェックだ。 https://t.co/z9q5nN9BqX
RT @VincentRK: And a very useful Table from this paper. https://t.co/qTxVvTWfce https://t.co/S0Kn6b6IRs
SARS-CoV-2 Vaccines: Status Report Fatima Amanat and Florian Krammer Immunity Apr 6 2020 https://t.co/sqJnhaQkK5
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ - GIGAZINE https://t.co/Yp7oFdKzA3
Core Pubmed: SARS-CoV-2 Vaccines: Status Report.: Related Articles SARS-CoV-2 Vaccines: Status Report. Immunity. 2020 04 14;52(4):583-589 Authors: Amanat F, Krammer F Abstract SARS-CoV-2, the causal agent of COVID-19,… https://t.co/CpC9quqXkr #coronavirus #SARS_CoV_2 #covid19
【#ディープラーニング #SARS-CoV-2】新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ これは必見ですね。https://t.co/CJXuGjo0SZ https://t.co/IG7WPX27hx
@AlvaroLladser @cpvio @WHO "Given that the population is currently naive to SARS-CoV- 2, it is highly likely that more than one dose of the vaccine will be needed. Prime-boost vaccination regimens are typically used with two vaccinations usually spaced 3–4 weeks apart".. extracto de https://t.co/fSAad9goES
RT @VincentRK: 7) A great resource on COVID vaccine development process and timelines: @FatimaAmanat @florian_krammer paper in Cell. @CellP…
SARS-CoV-2 Vaccines: Status Report https://t.co/xh68ga8lIC
RT @blopeur: SARS-CoV-2 Vaccines: Status Report If you want to know what's happening on the #COVID19 #vaccine front you need to read this…
SARS-CoV-2 Vaccines: Status Report If you want to know what's happening on the #COVID19 #vaccine front you need to read this report https://t.co/eZ50uRXafd https://t.co/98PaiDSKGC
RT @ImmunityCP: ICYMI: Perspective from @florian_krammer & @FatimaAmanat on #vaccine development for #SARSCoV2: "SARS-CoV-2 Vaccines: Statu…
Brilliant series by a Professor at Columbia University from the Department of Bioinformatics. Especially interesting his presentation of the insights offered regarding the value of instantaneous Contact Tracking over the seemingly sterile manual approach https://t.co/gkn5F3Uajg
RT @ImmunityCP: ICYMI: Perspective from @florian_krammer & @FatimaAmanat on #vaccine development for #SARSCoV2: "SARS-CoV-2 Vaccines: Statu…
https://t.co/Zsx9eE5v5d Really cool weekly series from @nicktatonetti on SARS-CoV-2 research
RT @ImmunityCP: ICYMI: Perspective from @florian_krammer & @FatimaAmanat on #vaccine development for #SARSCoV2: "SARS-CoV-2 Vaccines: Statu…
RT @Gui_Pap: Fantastic review on vaccine development for #SARS_COV_2 https://t.co/LzFP7QSdTL
Fantastic review on vaccine development for #SARS_COV_2 https://t.co/LzFP7QSdTL
RT @ImmunityCP: ICYMI: Perspective from @florian_krammer & @FatimaAmanat on #vaccine development for #SARSCoV2: "SARS-CoV-2 Vaccines: Statu…
RT @ImmunityCP: ICYMI: Perspective from @florian_krammer & @FatimaAmanat on #vaccine development for #SARSCoV2: "SARS-CoV-2 Vaccines: Statu…
RT @ImmunityCP: ICYMI: Perspective from @florian_krammer & @FatimaAmanat on #vaccine development for #SARSCoV2: "SARS-CoV-2 Vaccines: Statu…
RT @ImmunityCP: ICYMI: Perspective from @florian_krammer & @FatimaAmanat on #vaccine development for #SARSCoV2: "SARS-CoV-2 Vaccines: Statu…
RT @ImmunityCP: ICYMI: Perspective from @florian_krammer & @FatimaAmanat on #vaccine development for #SARSCoV2: "SARS-CoV-2 Vaccines: Statu…
RT @ImmunityCP: ICYMI: Perspective from @florian_krammer & @FatimaAmanat on #vaccine development for #SARSCoV2: "SARS-CoV-2 Vaccines: Statu…
RT @ImmunityCP: ICYMI: Perspective from @florian_krammer & @FatimaAmanat on #vaccine development for #SARSCoV2: "SARS-CoV-2 Vaccines: Statu…
RT @ImmunityCP: ICYMI: Perspective from @florian_krammer & @FatimaAmanat on #vaccine development for #SARSCoV2: "SARS-CoV-2 Vaccines: Statu…
RT @miyatamitsuru: ワクチン開発の現状と課題がとても良くわかります。モダリティごとの表も理解を助けます。 SARS-CoV-2 Vaccines: Status Report: Immunity https://t.co/Tn5KWlv4lN
RT @ImmunityCP: ICYMI: Perspective from @florian_krammer & @FatimaAmanat on #vaccine development for #SARSCoV2: "SARS-CoV-2 Vaccines: Statu…
RT @miyatamitsuru: ワクチン開発の現状と課題がとても良くわかります。モダリティごとの表も理解を助けます。 SARS-CoV-2 Vaccines: Status Report: Immunity https://t.co/Tn5KWlv4lN
RT @ImmunityCP: ICYMI: Perspective from @florian_krammer & @FatimaAmanat on #vaccine development for #SARSCoV2: "SARS-CoV-2 Vaccines: Statu…
ワクチン開発状況。開発一覧表が便利。→ SARS-CoV-2 Vaccines: Status Report https://t.co/RvS9YoQQms
RT @miyatamitsuru: ワクチン開発の現状と課題がとても良くわかります。モダリティごとの表も理解を助けます。 SARS-CoV-2 Vaccines: Status Report: Immunity https://t.co/Tn5KWlv4lN
ワクチン開発の現状と課題がとても良くわかります。モダリティごとの表も理解を助けます。 SARS-CoV-2 Vaccines: Status Report: Immunity https://t.co/Tn5KWlv4lN
RT @ImmunityCP: ICYMI: Perspective from @florian_krammer & @FatimaAmanat on #vaccine development for #SARSCoV2: "SARS-CoV-2 Vaccines: Statu…
RT @ImmunityCP: ICYMI: Perspective from @florian_krammer & @FatimaAmanat on #vaccine development for #SARSCoV2: "SARS-CoV-2 Vaccines: Statu…
RT @ImmunityCP: ICYMI: Perspective from @florian_krammer & @FatimaAmanat on #vaccine development for #SARSCoV2: "SARS-CoV-2 Vaccines: Statu…
RT @ImmunityCP: ICYMI: Perspective from @florian_krammer & @FatimaAmanat on #vaccine development for #SARSCoV2: "SARS-CoV-2 Vaccines: Statu…
RT @ImmunityCP: ICYMI: Perspective from @florian_krammer & @FatimaAmanat on #vaccine development for #SARSCoV2: "SARS-CoV-2 Vaccines: Statu…
RT @ImmunityCP: ICYMI: Perspective from @florian_krammer & @FatimaAmanat on #vaccine development for #SARSCoV2: "SARS-CoV-2 Vaccines: Statu…
RT @ImmunityCP: ICYMI: Perspective from @florian_krammer & @FatimaAmanat on #vaccine development for #SARSCoV2: "SARS-CoV-2 Vaccines: Statu…
RT @ImmunityCP: ICYMI: Perspective from @florian_krammer & @FatimaAmanat on #vaccine development for #SARSCoV2: "SARS-CoV-2 Vaccines: Statu…
ICYMI: Perspective from @florian_krammer & @FatimaAmanat on #vaccine development for #SARSCoV2: "SARS-CoV-2 Vaccines: Status Report" https://t.co/HPDhHs2PSc #COVID19 #openaccess https://t.co/h36fVNsPLn
RT @nicktatonetti: In this week's episode of #TheC19Weekly we discuss #vaccines, #transcriptomics data, and what models of digital contact…
To my fellow scientists who want to keep up to date with the latest COVID-19 research developments - I highly recommend this Youtube series. Every week Columbia Professor, Nick Tatonetti discuss 3 high profile/impact papers. Good stuff! #Covid19 #research https://t.co/LPvqtrOIBh
@santosharyal9 @RaameshKoirala Read a review on current status of COVID vaccine development &point out future possibilities&challenges? https://t.co/JITwwB6bgs
非常に細かく、またわかりやすい。/新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ - GIGAZINE https://t.co/nGgay5QFOS
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ - GIGAZINE https://t.co/BAPiEZUFxs
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ #technology https://t.co/c5Ap81KLnc
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ - GIGAZINE https://t.co/pCUHJ7qw6I
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ - GIGAZINE https://t.co/gRMePuHYgm …終息に…人口の７割程度の免疫保持者がと…!?(^^;
RT @nicktatonetti: In this week's episode of #TheC19Weekly we discuss #vaccines, #transcriptomics data, and what models of digital contact…
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ - GIGAZINE https://t.co/q7ITXNIxMR
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ - GIGAZINE https://t.co/G5i0GwEyvB
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ - GIGAZINE https://t.co/W8zGOgeM4i
RT @gorka_orive: Información completa y detallada del proceso de obtención de una vacuna frente a la #COVID19. Desde el diseño biológico al…
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ - GIGAZINE https://t.co/KzPzZa8tcl
RT @gorka_orive: Información completa y detallada del proceso de obtención de una vacuna frente a la #COVID19. Desde el diseño biológico al…
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ https://t.co/9CVmyonEcl
SARS-CoV-2 Vaccines: Status Report: Immunity https://t.co/WEn9WwLbZZ
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ https://t.co/G3HBoio9H2
https://t.co/n2ALjy7dvu
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ https://t.co/ZecbuGQABl
というか、今回の件でに限らず元々薬は10~15年の開発期間ですけどね→ 新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ - GIGAZINE https://t.co/i41sMNlTSW
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ - GIGAZINE https://t.co/K5hD4TWQJs
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ - GIGAZINE https://t.co/cxsmfTWG4o
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ - GIGAZINE https://t.co/gRMePuHYgm …ワクチン開発…!?(^^;
SARS-CoV-2 Vaccines: Status Report https://t.co/FalqYNaiSa
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ - GIGAZINE https://t.co/dsD3xLBLwe
RT @gigazine: 新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ https://t.co/3bDtYJWBnA
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ - GIGAZINE https://t.co/AFxiKDf3qZ
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ - GIGAZINE https://t.co/uekPB5AQXZ
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ - GIGAZINE https://t.co/46i7GF9WlW
RT @gigazine: 新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ https://t.co/3bDtYJWBnA
RT @nicktatonetti: In this week's episode of #TheC19Weekly we discuss #vaccines, #transcriptomics data, and what models of digital contact…
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ - GIGAZINE https://t.co/6kA0ZIDg96
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ https://t.co/GVieS9fqIX
Reporte del estado del arte de la vacuna contra el #SARSCoV2 #covid19 https://t.co/93UnryXEZY
RT @gigazine: 新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ https://t.co/3bDtYJWBnA
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ - GIGAZINE https://t.co/QPpBencj13
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ #SmartNews https://t.co/rNol4lc4Tr
RT @nicktatonetti: In this week's episode of #TheC19Weekly we discuss #vaccines, #transcriptomics data, and what models of digital contact…
RT @serdelor: Nice review about #SARS_COV_2 from @florian_krammer and @FatimaAmanat https://t.co/CiymeuJyy7
RT @gigazine: 新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ https://t.co/3bDtYJWBnA
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ - GIGAZINE https://t.co/IvOWOgEgS7
RT @gigazine: 新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ https://t.co/3bDtYJWBnA
新型コロナウイルスのワクチン開発にはなぜ年単位の時間が必要なのか？ - GIGAZINE https://t.co/yymftwbsFf
RT @serdelor: Nice review about #SARS_COV_2 from @florian_krammer and @FatimaAmanat https://t.co/CiymeuJyy7
RT @serdelor: Nice review about #SARS_COV_2 from @florian_krammer and @FatimaAmanat https://t.co/CiymeuJyy7
RT @nicktatonetti: In this week's episode of #TheC19Weekly we discuss #vaccines, #transcriptomics data, and what models of digital contact…
In this week's episode of #TheC19Weekly we discuss #vaccines, #transcriptomics data, and what models of digital contact tracing mean for the @apple/@google collaboration. Catch it all here: https://t.co/g3WlMJdGjx #COVID19 #coronavirus #DataScience @AMIAinformatics
Nice review about #SARS_COV_2 from @florian_krammer and @FatimaAmanat https://t.co/CiymeuJyy7
RT @VincentRK: And a very useful Table from this paper. https://t.co/qTxVvTWfce https://t.co/S0Kn6b6IRs
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
Even if short-cuts for several of the steps can be found, it is unlikely that a #Covid-19 #vaccine would be available earlier than 6 months after the initiation of clinical trials. Realistically, A vaccine will not be available for another 12–18 months https://t.co/JJCfdoeWO2
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @TwistBioscience: Really thorough paper detailing current drug therapies and #vaccine efforts for #COVID19. @FatimaAmanat, @florian_kram…
RT @TwistBioscience: Really thorough paper detailing current drug therapies and #vaccine efforts for #COVID19. @FatimaAmanat, @florian_kram…
Really thorough paper detailing current drug therapies and #vaccine efforts for #COVID19. @FatimaAmanat, @florian_krammer, @IcahnMountSinai SARS-CoV-2 Vaccines: Status Report https://t.co/QSJosG7XZv
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @ShorterLab: SARS-CoV-2 Vaccines: Status Report: https://t.co/17MZNyx6Yv
RT @syinvesting: @NatRevDrugDisc #COVID19 Detailed review of SARS-CoV-2 vaccines from @CellPressNews @ImmunityCP "Realistically, SARS-CoV-…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @ShorterLab: SARS-CoV-2 Vaccines: Status Report: https://t.co/17MZNyx6Yv
RT @Transplant_Doc: SARS-CoV-2 Vaccines: Status Report. An excellent review on the status of vaccine development for SARS-CoV-2 https://t.c…
RT @ShorterLab: SARS-CoV-2 Vaccines: Status Report: https://t.co/17MZNyx6Yv
RT @ShorterLab: SARS-CoV-2 Vaccines: Status Report: https://t.co/17MZNyx6Yv
RT @VincentRK: And a very useful Table from this paper. https://t.co/qTxVvTWfce https://t.co/S0Kn6b6IRs
@NatRevDrugDisc #COVID19 Detailed review of SARS-CoV-2 vaccines from @CellPressNews @ImmunityCP "Realistically, SARS-CoV-2 vaccines will not be available for another 12–18 months." Paper: https://t.co/Aln7mnwJVW https://t.co/qfSJTgnC0V
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @VincentRK: And a very useful Table from this paper. https://t.co/qTxVvTWfce https://t.co/S0Kn6b6IRs
RT @VincentRK: 7) A great resource on COVID vaccine development process and timelines: @FatimaAmanat @florian_krammer paper in Cell. @CellP…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
SARS-CoV-2 Vaccines: Status Report. An excellent review on the status of vaccine development for SARS-CoV-2 https://t.co/8qbz0SDCop #COVID19 #coronavirus @ImmunityCP @FatimaAmanat @florian_krammer
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @CaKizil: Halihazırdaki aşı çalışmalarının doğası ve neden uzun süreceğine dair bir derleme bugün @ImmunityCP’de yayımlandı. #coronaviru…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @arielo_cerda: #CoronaFacts: A los interesados en vacunas contra #SARS_COV_2, la revista Immunity hace pocos días saco un "Status Report…
#CoronaFacts: A los interesados en vacunas contra #SARS_COV_2, la revista Immunity hace pocos días saco un "Status Report" con algunas consideraciones, estudios en cursos y posibles soluciones. Dejo el enlace acá (https://t.co/FnPSUAvfIn)y adjunto una tabla resumen del artículo. https://t.co/zjVPVRMTt6
#SARS-CoV-2 Vaccines: Status Report: https://t.co/NF1JWtDQxS
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
RT @VincentRK: I had asked this before on vaccines for COVID. How much time is due to compliance & regulatory issues? Since we are in phase…
RT @EricTopol: I had missed this terrific review on #COVID19 vaccine prospects by @FatimaAmanat & @florian_krammer @ImmunityCP https://t.co…
A che punto siamo con lo sviluppo dei vaccini contro il #coronavirus? https://t.co/HiWOUMfKpf
Vaccins SARS-CoV-2: Rapport de Situation https://t.co/V1pgxr5181 https://t.co/wHdHpudK8S
RT @ResearchTrauma: If you are interested to know the status of #SARSCoV2 #vaccine. Copied below the link. Thank you @ImmunityCP make it fr…
Vacinas para #COVID19 . Ainda vai demorar muito para uma vacina segura e eficaz. Alguns tipos de vacinas geram preocupação porque nunca foram testadas antes, como as vacinas feita de RNA mensageiro para manipular nossas células para produzir antígenos. https://t.co/gRa25mDtIo
RT @Lo_Zanzi: Everything you might want to know about the future #vaccine against #SARSCoV2 #COVID19 @florian_krammer @ImmunityCP @Immunosc…
RT @Lo_Zanzi: Everything you might want to know about the future #vaccine against #SARSCoV2 #COVID19 @florian_krammer @ImmunityCP @Immunosc…
RT @Lo_Zanzi: Everything you might want to know about the future #vaccine against #SARSCoV2 #COVID19 @florian_krammer @ImmunityCP @Immunosc…
RT @pzhong2016: SARS-CoV-2 Vaccines: Status Report https://t.co/oU2ePnWaLw https://t.co/sefi85x0G5
SARS-CoV-2 Vaccines: Status Report https://t.co/oU2ePnWaLw https://t.co/sefi85x0G5
RT @ResearchTrauma: If you are interested to know the status of #SARSCoV2 #vaccine. Copied below the link. Thank you @ImmunityCP make it fr…
RT @Lo_Zanzi: Everything you might want to know about the future #vaccine against #SARSCoV2 #COVID19 @florian_krammer @ImmunityCP @Immunosc…
RT @ResearchTrauma: If you are interested to know the status of #SARSCoV2 #vaccine. Copied below the link. Thank you @ImmunityCP make it fr…
RT @ResearchTrauma: If you are interested to know the status of #SARSCoV2 #vaccine. Copied below the link. Thank you @ImmunityCP make it fr…
RT @ResearchTrauma: If you are interested to know the status of #SARSCoV2 #vaccine. Copied below the link. Thank you @ImmunityCP make it fr…
RT @ResearchTrauma: If you are interested to know the status of #SARSCoV2 #vaccine. Copied below the link. Thank you @ImmunityCP make it fr…
RT @ResearchTrauma: If you are interested to know the status of #SARSCoV2 #vaccine. Copied below the link. Thank you @ImmunityCP make it fr…
RT @ResearchTrauma: If you are interested to know the status of #SARSCoV2 #vaccine. Copied below the link. Thank you @ImmunityCP make it fr…
If you are interested to know the status of #SARSCoV2 #vaccine. Copied below the link. Thank you @ImmunityCP make it free for all. https://t.co/BtlM89bGId https://t.co/HiRxaQcemn
Everything you might want to know about the future #vaccine against #SARSCoV2 #COVID19 @florian_krammer @ImmunityCP @Immunoscope @Immune_News https://t.co/UM3QUU8nlK
SARS-CoV-2 hedefli aşı üretimi ilk pandemi dalgası için çok geç olabilir, ancak sonraki dalgalarda işe yarayabilir. Makale burada: https://t.co/IpzNKUlVR8 Hızlı, etkin ve ucuz bir tedavi stratejisi geliştirilmeli, bir an önce...#vaka30217
RT @Inmunociad: Un resumen de las opciones para la producción de una vacuna para el virus SARS-Cov-2. Una adaptación de un trabajo de Fat…
RT @Inmunociad: Un resumen de las opciones para la producción de una vacuna para el virus SARS-Cov-2. Una adaptación de un trabajo de Fat…
RT @Inmunociad: Un resumen de las opciones para la producción de una vacuna para el virus SARS-Cov-2. Una adaptación de un trabajo de Fat…
RT @Inmunociad: Un resumen de las opciones para la producción de una vacuna para el virus SARS-Cov-2. Una adaptación de un trabajo de Fat…
RT @Inmunociad: Un resumen de las opciones para la producción de una vacuna para el virus SARS-Cov-2. Una adaptación de un trabajo de Fat…
Un resumen de las opciones para la producción de una vacuna para el virus SARS-Cov-2. Una adaptación de un trabajo de Fatima Amanat y @florian_krammer DOI: 10.1016/j.immuni.2020.03.007 #SARS_COV_2 #vaccine #vacunas https://t.co/CB9OxPylKO